Immune modulation by altered nutrient metabolism: nutritional control of immune-induced growth depression.
The ability of conjugated isomers of linoleic acid (CLA) to prevent reduced growth rate following endotoxin (lipopolysaccharide, LPS) injection was studied in two chick trials and one rat trial. Chicks (10 per treatment) were fed a corn and soybean meal-based diet with or without .5% CLA. At 21 days of age, chicks were weighed and injected i.p. with 1 mg/kg BW Escherichia coli LPS and sterile PBS. Body weights were again determined 24 h later. Antibody responses to SRBC were also determined. Rats fed .5% stearic acid or CLA for 4 wk (seven per treatment) were also injected with LPS, and BW change over a 24-h postinjection period was determined. Antibody responses to BSA, phytohemagglutinin foot pad swelling, and phagocytosis of elicited peritoneal macrophages were also determined. The CLA had no adverse effects on any immune variables measured in the chicks and rats. The CLA enhanced the phytohemagglutinin response and macrophage phagocytosis in rats. Chicks fed CLA and injected with LPS continued to grow, whereas those not fed CLA either failed to grow or lost weight following LPS injection. Both control and CLA-fed rats lost weight over the 24-h period after LPS injection; however, the loss of weight in rats fed CLA was only half of the weight loss of the control rats. Thus, CLA is effective in preventing the catabolic effects of immune stimulation.
Cook
M E
ME
Department of Poultry Science, University of Wisconsin, Madison 53706.
Miller
C C
CC
Park
Y
Y
Pariza
M
M
D000818:Animals; D000906:Antibodies / Q000097:blood; D002645:Chickens / Q000254:growth & development / Q000276:immunology* / Q000378:metabolism; D004926:Escherichia coli; D005527:Food, Fortified; D006130:Growth Disorders / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D007114:Immunization; D008041:Linoleic Acids / Q000008:administration & dosage*; D008070:Lipopolysaccharides / Q000008:administration & dosage; D051381:Rats; D015431:Weight Loss / Q000187:drug effects*
D000906:Antibodies; D008041:Linoleic Acids; D008070:Lipopolysaccharides